The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
SIRION BIOTECH
Planegg, Germany
A
11-50 Employees
2007
Key takeaway
SIRION Biotech specializes in optimizing adeno-associated vectors (AAV) and lentiviral vectors, which are crucial for in vivo gene therapy applications. With over 15 years of experience in viral vector development and a focus on therapeutic expression cassette optimization, the company supports the entire gene therapy development process from R&D to GMP production.
Reference
Product
Cell Therapy (LV Technologies)
Lentiviral vectors integrate stably into the genome and are thus a reliable tool for ex vivo gene therapy or cell therapy.
GeneWerk
Heidelberg, Germany
A
11-50 Employees
2014
Key takeaway
GeneWerk, now known as ProtaGene, specializes in gene therapy safety solutions, particularly addressing insertional mutagenesis and genotoxicity. Their expertise is crucial for developing safer gene therapies, making them a valuable partner in the field of cell and gene therapy development.
Reference
Core business
Gene Therapy | Insertional Mutagenesis | Genotoxicity
GeneWerk are providers of gene therapy safety solutions focusing on insertional mutagenesis and genotoxicity to bring breakthrough therapies to clinics.
ViGeneron
Starnberg, Germany
A
1-10 Employees
2017
Key takeaway
ViGeneron is focused on delivering innovative gene therapies, particularly for ophthalmic diseases with high unmet medical needs. Their pipeline includes programs targeting inherited retinal diseases, utilizing proprietary adeno-associated virus (AAV) technology platforms.
Reference
Core business
ViGeneron - The next generation gene therapy companyViGeneron
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
EUFETS GmbH
Idar-Oberstein, Germany
A
1-10 Employees
-
Key takeaway
BioNTech IMFS specializes in the industrialization of cell and gene therapy products, including the manufacturing of GMP grade IVT mRNA that can be used for in vivo applications. With extensive expertise and a state-of-the-art facility, they support the development and manufacturing of retroviral vectors for clinical supply, contributing to numerous clinical trials for gene therapy worldwide.
Reference
Product
VIRAL VECTORS - BioNTech IMFS
Protagen Protein Services
Dortmund, Germany
A
101-250 Employees
1997
Key takeaway
ProtaGene offers specialized molecular bioanalytical solutions specifically designed for gene therapy developers. Their advanced capabilities support projects from research to commercial release, providing essential analytical support for biotherapeutics and gene and cell therapies.
Reference
Core business
ProtaGene | Analytical Excellence | Biologic Drug & Cell & Gene Therapy
ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms.
InVivo Biotech Services GmbH
Hennigsdorf, Germany
A
51-100 Employees
1998
Key takeaway
InVivo BioTech Services GmbH specializes in mammalian cell culture and the production of recombinant proteins, offering a comprehensive service portfolio that includes antibody development and production. Their expertise and innovative solutions, such as the InVEST expression system for transient transfection, position them as a key player in the field of gene therapy.
Reference
Core business
News - InVivo Biotech Services
Transient Transfection
Hennigsdorf, Germany
A
1-10 Employees
-
Key takeaway
InVivo specializes in transient transfection, a method for delivering DNA into mammalian cells that allows for temporary gene expression. This technique is particularly valuable for the rapid production of high-grade recombinant proteins, making it an important aspect of early pre-clinical and biochemical characterization studies in the drug development pipeline.
Reference
Service
Transient Transfection Services by InVivo
InVivo has invested several years into research to gain the best results for your project. Rely on us for your outsourcing needs!
Miltenyi Biomedicine
Bergisch Gladbach, Germany
A
51-100 Employees
2019
Key takeaway
Miltenyi Biomedicine is actively developing innovative cell and gene therapies, particularly focusing on cancer treatments and regenerative therapies. Their commitment to creating effective cures includes the use of CAR T technology for difficult-to-treat hematological cancers, aiming to enhance patient outcomes and reduce treatment waiting times.
Reference
Core business
Personalized cell and gene therapy | Miltenyi Biomedicine
Miltenyi Biomedicine GmbH develops innovative cell and gene therapies. We are focused on bringing cancer treatments and regenerative therapies to patients.
AaviGen GmbH
Heidelberg, Germany
A
1-10 Employees
2019
Key takeaway
AaviGen is dedicated to revolutionizing cardiovascular medicine through innovative heart-specific gene therapies, utilizing their advanced organ-specific Adeno-Associated Viral vectors (AAV) to improve patient outcomes. Their focus on molecular and translational research positions them at the forefront of in vivo gene therapy development for cardiac care.
Reference
Core business
AaviGen
Gen-H Genetic Engineering Heidelberg GmbH
Heidelberg, Germany
A
1-10 Employees
-
Key takeaway
Gen-H's expertise in genetic engineering, particularly through Red/ET recombination, positions them as a valuable resource for developing complex targeting constructs for animal models, which is highly relevant to in vivo gene therapy. Their collaboration with academic and industrial clients highlights their capability to support innovative genetic modifications.
Reference
Core business
Company • GEN-H
Technologies which have been searched by others and may be interesting for you:
In the In Vivo Gene Therapy industry in Germany, several key considerations are critical for prospective researchers or investors. Regulatory compliance is paramount, as Germany follows stringent EU regulations regarding gene therapy products, requiring extensive clinical trials and safety evaluations. The German medical and pharmaceutical landscape is robust, offering opportunities for collaboration with leading universities and research institutions, which can enhance innovation. However, challenges such as high research and development costs and the complexity of manufacturing gene therapies can pose significant barriers. The competitive landscape features a mix of established companies and emerging biotech firms, each striving to develop novel therapies that address various genetic disorders. Additionally, there is a growing emphasis on sustainable practices and ethical considerations, particularly concerning environmental impacts and patient safety. The global relevance of the German market is significant, as it is one of the leading hubs for biopharmaceutical development in Europe, attracting investments and fostering advancements in gene therapies. Understanding these factors will provide valuable insights for anyone looking to navigate the In Vivo Gene Therapy sector in Germany effectively.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | Germany |
| Amount of fitting manufacturers | 622 |
| Amount of suitable service providers | 495 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1997 |
| Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Other, Biotechnology, Medical, Pharmaceuticals, Healthcare
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
